eToro Group Ltd. (ETOR), a trading and investing platform, has appointed Laura Unger and Lior Shemesh to its Board of Directors. Both will also join eToro’s Audit & Risk Committee. The company stated that these appointments support its governance and risk management efforts as it plans to expand in the U.S. following its Nasdaq listing.

eToro Adds Two Financial Experts to Board

Unger is a former U.S. Securities and Exchange Commission (SEC) Commissioner and Acting Chair.

She has more than twenty years of experience in financial regulation, including roles at the U.S. Senate Banking Committee and on corporate boards such as Nomura Holdings.

Shemesh has been the Chief Financial Officer (CFO) of Wix since 2013.

He has financial leadership experience from his work at technology companies including Alverion Ltd. and Veraz Networks Inc.

Analysts See Upside for eToro Shares

Meanwhile, eToro shares have seen price fluctuations since their May 2025 IPO, currently trading at $63.42, down 1.4% from the previous session. The stock has declined over 20% from June highs but remains above its IPO offering price.

You may find it interesting at FinanceMagnates.com: The Big Winners of eToro IPO: Who’s Set to Gain the Most?

Seven investment firms have issued “Strong Buy” ratings, with price targets as high as $85. Analysts cite expanding retail investor activity and long-term growth potential. eToro also secured a $250 million credit facility following its listing. Technical analysis shows support near $58–60 and resistance around $68. The average analyst price target stands at $75.20, implying a potential 12.9% upside.

eToro Posts First Results Since IPO

Earlier, eToro released its first quarterly results as a public company for the period ending March 31, 2025. Net contribution rose 8% year-over-year to $217 million, supported by higher trading volumes. GAAP net income declined to $60 million from $64 million, due to increased marketing and investment spending.

Adjusted EBITDA fell to $80 million, with the margin narrowing to 37%. Funded accounts grew 14% to 3.58 million, while Assets under Administration rose 21% to $14.8 billion. The company held $736 million in liquid assets.

This article was written by Tareq Sikder at www.financemagnates.com.ExecutivesRead More

You might also be interested in reading Pfizer settles Biohaven kickback case with DOJ for $60M.